What is the TrumpRX New Website?

Struggling with high US drug costs? The TrumpRX new website could help. President Trump launched this initiative to offer discounted medicines from Pfizer and others. 

It promotes most-favored-nation pricing, matching lower rates from countries like Canada and Germany. This ends Americans footing the bill for global R&D. Expect big savings on prescriptions via TrumpRX.gov.

Want to trade crypto while reading our latest news? Head over to Bitrue and explore your options today!

Pfizer Partnership and Announcement

President Trump unveiled the TrumpRX plan in a White House event with Pfizer CEO Albert Bourla. The deal makes Pfizer the pioneer in slashing prices for Medicaid and direct buys. 

New drugs will launch at global low rates, boosting access for everyday folks. Bourla hailed it as fixing unfair global pricing.

Deal Highlights and Discounts

Pfizer commits to 50% average cuts on primary care and select specialty meds via TrumpRX. Examples include:

• Duavee for menopause: down 85% to $30

• Toviaz for bladder issues: 85% off to $42

• Eucrisa ointment: 80% reduction to $162

These TrumpRX discounts beat list prices, aiding cash payers. New meds get most-favored-nation rates too.

In return, Pfizer skips tariffs for three years and invests $70 billion in US manufacturing and R&D. This boosts jobs and innovation while dodging 100% import duties.

Read Also: Is There Another Tariff Agreement from China and the US?

How the TrumpRX Website Operates

TrumpRX.gov launches early 2026 as a federal hub. It doesn't stock drugs but links users to pharma sites for direct buys at reduced rates. Search your med, get redirected, and pay cash for discounts, ideal for uninsured or high-deductible plans.

This builds on trends like Eli Lilly's direct sales. It skips middlemen like pharmacy benefit managers, potentially saving millions yearly. Details on exact savings calculations remain private, but it's a step toward fairer medicine plans.

Ideal Users for TrumpRX Savings

TrumpRX shines for those without insurance coverage. Key benefits include:

• Avoiding high list prices on brand-name drugs

• Access to Pfizer's portfolio at up to 85% off

• Medicaid patients gaining most-favored-nation deals

• Insured folks might still get better pharmacy rebates, per experts.

Critics note Medicaid already scores low prices, so taxpayer gains may be modest. Harvard's Ameet Sarpatwari calls it more optics than overhaul for broad relief.

Read Also: Emma Walmsley Steps Down from CEO of GSK

Push for Fair Drug Pricing Background

It all started with Trump's May 2025 executive order on most-favored-nation pricing. US prices are triple those abroad due to no government caps. The plan targets this gap, pressuring firms via letters to 17 makers.

July demands included matching foreign rates, direct sales, and Medicaid cuts, or face tariffs. PhRMA's similar site launches soon, showing industry response.

Tariff Leverage in the Plan

Tariffs from national security probes motivated Pfizer. Bourla admitted they're a "powerful tool" for change. The deal sets a template for others, promising more TrumpRX partners.

Read Also: Novo Nordisk (NVO) Stock Crashes 20%: What’s Behind the Sudden Drop?

Conclusion

TrumpRX.gov marks a bold move to cut drug costs, leveraging Pfizer's discounts and tariff threats. While not a complete fix, it sets a model for pharma accountability. 

Stay updated on new deals and explore platforms like Bitrue for savvy financial moves in these shifting times.

FAQ

What is TrumpRX.gov?

It’s a federal site launching in 2026 that links users to pharma websites for direct drug purchases at discounted rates.

How much can I save with TrumpRX?

Savings go up to 85%. For example, Duavee drops to $30 and Toviaz to $42.

Who benefits most from TrumpRX?

Uninsured and high-deductible patients gain the biggest savings since they skip inflated list prices.

Does TrumpRX replace pharmacies?

No. It doesn’t stock drugs, just redirects you to pharma sites for direct, cheaper buys.

Why did Pfizer join TrumpRX?

To avoid 100% import tariffs and secure a 3-year exemption, while pledging $70B for US R&D and jobs.

Bitrue Official Website: 

Website: https://www.bitrue.com/

Sign Up: https://www.bitrue.com/user/register

Disclaimer: The views expressed belong exclusively to the author and do not reflect the views of this platform. This platform and its affiliates disclaim any responsibility for the accuracy or suitability of the information provided. It is for informational purposes only and not intended as financial or investment advice.